BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30509965)

  • 1. Clinical utility of microRNA-451 as diagnostic biomarker for human cancers.
    Li Z; Li Y; Fu J; Li N; Shen L
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30509965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical utility of microRNA-378 as early diagnostic biomarker of human cancers: a meta-analysis of diagnostic test.
    Li ZZ; Shen LF; Li YY; Chen P; Chen LZ
    Oncotarget; 2016 Sep; 7(36):58569-58578. PubMed ID: 27448977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical use of microRNAs as potential non-invasive biomarkers for detecting non-small cell lung cancer: a meta-analysis.
    Wang H; Wu S; Zhao L; Zhao J; Liu J; Wang Z
    Respirology; 2015 Jan; 20(1):56-65. PubMed ID: 25440223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential Role of MicroRNA-375 as Biomarker in Human Cancers Detection: A Meta-Analysis.
    Yan J; She Q; Shen X; Zhang Y; Liu B; Zhang G
    Biomed Res Int; 2017; 2017():1875843. PubMed ID: 29259977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-223 in gastrointestinal cancers: A systematic review and diagnostic meta-analysis.
    Aalami AH; Abdeahad H; Mesgari M; Sahebkar A
    Eur J Clin Invest; 2021 Feb; 51(2):e13448. PubMed ID: 33244751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical utility of microRNA-21 as novel biomarker for diagnosing human cancers.
    Shen L; Wan Z; Ma Y; Wu L; Liu F; Zang H; Xin S
    Tumour Biol; 2015 Mar; 36(3):1993-2005. PubMed ID: 25431259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum microRNA-21 as a potential diagnostic biomarker for breast cancer: a systematic review and meta-analysis.
    Li S; Yang X; Yang J; Zhen J; Zhang D
    Clin Exp Med; 2016 Feb; 16(1):29-35. PubMed ID: 25516467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential diagnostic accuracy of circulating microRNAs for prostate cancer: A meta-analysis.
    Zhang WT; Zhang GX; Zhao RZ; Gao SS
    Actas Urol Esp (Engl Ed); 2022 Apr; 46(3):138-149. PubMed ID: 35260368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic performance of circular RNAs in human cancers: A systematic review and meta-analysis.
    Li J; Li H; Lv X; Yang Z; Gao M; Bi Y; Zhang Z; Wang S; Cui Z; Zhou B; Yin Z
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00749. PubMed ID: 31106993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Potential Diagnostic Accuracy of Let-7 Family for Cancer: A Meta-Analysis.
    Zhang WT; Zhang GX; Gao SS
    Technol Cancer Res Treat; 2021; 20():15330338211033061. PubMed ID: 34259101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-145 as ideal biomarker for the diagnosis of various carcinomas.
    Hou Y; Wang X; Chen Y; Mu S
    Tumour Biol; 2015 Apr; 36(4):2641-9. PubMed ID: 25476854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs as Biomarkers for the Diagnostics of Bladder Cancer: a Meta-Analysis.
    Chen L; Cui Z; Liu Y; Bai Y; Lan F
    Clin Lab; 2015; 61(8):1101-8. PubMed ID: 26427157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating miRNAs as novel potential biomarkers for esophageal squamous cell carcinoma diagnosis: a meta-analysis update.
    Liu F; Tian T; Xia LL; Ding Y; Cormier RT; He Y
    Dis Esophagus; 2017 Feb; 30(2):1-9. PubMed ID: 27003597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-21 as a potential diagnostic biomarker for breast cancer patients: a pooled analysis of individual studies.
    Gao Y; Cai Q; Huang Y; Li S; Yang H; Sun L; Chen K; Wang Y
    Oncotarget; 2016 Jun; 7(23):34498-506. PubMed ID: 27153564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating microRNA-21 as a biomarker for the detection of various carcinomas: an updated meta-analysis based on 36 studies.
    Wu K; Li L; Li S
    Tumour Biol; 2015 Mar; 36(3):1973-81. PubMed ID: 25527152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain tumors and circulating micrornas: a systematic review and diagnostic meta-analysis.
    Aalami AH; Abdeahad H; Shoghi A; Mesgari M; Amirabadi A; Sahebkar A
    Expert Rev Mol Diagn; 2022 Feb; 22(2):201-211. PubMed ID: 34906021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Accuracy of Single MicroRNAs in Peripheral Blood to Diagnose Ovarian Cancer: An Updated Meta-Analysis.
    Cui Y; Hong S; Zhu X
    Dis Markers; 2020; 2020():1075942. PubMed ID: 32025275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomal miRNAs as Biomarkers of Cancer: a Meta-Analysis.
    Yang B; Xiong WY; Hou HJ; Xu Q; Cai XL; Zeng TX; Ha XQ
    Clin Lab; 2019 May; 65(5):. PubMed ID: 31115208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical utility of serum fucosylated fraction of alpha-fetoprotein in the diagnostic of hepatocellular carcinoma: a comprehensive analysis with large sample size.
    Liu A; Li Y; Shen L; Shen L; Li Z
    Aging (Albany NY); 2022 Mar; 14(6):2645-2664. PubMed ID: 35307694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into the application of let-7 family as promising biomarker in cancer screening.
    Dai Y; Wang D; Tian X; Zhang L; Sui C; Meng F; Jiang S; Liu Y; Jiang Y
    Tumour Biol; 2015 Jul; 36(7):5233-9. PubMed ID: 25801240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.